An observational study in Obesity, sponsored by Novo Nordisk A/S. Completed at 9 sites in 9 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-06-14.
Sponsored by Novo Nordisk A/S · Observational
ACTION APAC is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor through existing databases/panels in APAC region.
The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.
6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.
This study's enrollment of 12,404 is above the median of 135 across 1,283 observational studies indexed under Obesity.
Browse Obesity studies →Novo Nordisk A/S is the lead sponsor of 1,370 studies on the registry; 102 are open to participants now.
Of its 198 completed or terminated interventional studies of FDA-regulated products, 94 (47%) have results posted.
Counted across the registry records on this site, refreshed daily.
The respondent population will include people living with obesity (PLwO) and health care professionals (HCPs) involved in obesity treatment and management.
People Living with Obesity
Health Care Professionals
Exclusion criteria:
People Living with obesity
Health Care Providers
From online, general population consumer panels
Other: No treatment given
HCPs treating people who have obesity
Other: No treatment given
No treatment given
Weight loss motivators for improving health of PLwO
Multi-select from defined list
Time frame: At the time of survey response (Day 1)
Weight loss barriers for improving health of PLwO
Multi-select from defined list
Time frame: At the time of survey response (Day 1)
Weight loss management for improving health of PLwO
Multi-select from defined list
Time frame: At the time of survey response (Day 1)
Weight loss responsibility for improving health of PLwO
Multi-select from defined list
Time frame: At the time of survey response (Day 1)
Proportion of PLwO who made serious weight loss effort
Number of weight loss efforts; percentage of patients
Time frame: At the time of survey response (Day 1)
Response to weight loss discussions
Single select from defined list
Time frame: At the time of survey response (Day 1)
Attitudes towards obesity and weight management and Interactions of PLwOs with HCPs
5-point Likert scales
Time frame: At the time of survey response (Day 1)
Plan to share: Yes — According to the Novo Nordisk disclosure commitment on novonordisk-trials.com
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Novo Nordisk A/S